Home AskBio

AskBio

acquired
Equity Financing
AAV Gene Therapy Developer

Basic Information

AskBio is a leading AAV gene therapy company co-founded in 2001 by Dr. Richard Jude Samulski, the first scientist in history to clone AAV, and Dr. Xiao Xiao, the first scholar to develop a mini-dystrophin gene, which facilitates gene therapy for Duchenne Muscular Dystrophy (DMD).
Asklepios BioPharmaceutical, Inc.
NorthCarolina,United States of America
unclear
January 01, 2003
--